Asthma rescue inhaler study after emergency visit
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new rescue inhaler (Airsupra) for people with asthma after an emergency visit. It may help you manage your asthma at home with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had acute asthma and are 18 to 54 years old.
- You speak English or Spanish.
- Your emergency doctor plans to send you home with steroid pills or liquid.
- You are willing to use Airsupra as your only rescue inhaler for 3 months (if in the study group).
- You can use an inhaler correctly and give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two versions of the common asthma rescue inhaler (salbutamol/albuterol) that use different propellants (the gas that pushes the medicine out). The goal is to see if the new propellant works as well as the current one. If you have mild asthma and are on a stable treatment plan, you may be able to join.
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
This study tests whether switching to a higher-dose or extrafine triple inhaler helps people whose asthma is still uncontrolled on their current medium-dose combination inhaler. It focuses on improving small-airway function, which may lead to better symptom control.
This study tests a new inhaled medication (given through a device you breathe in) for adults with asthma. It is designed to reduce inflammation and improve breathing, and may help people who have not found relief with standard daily inhalers.
This study tests a new combination inhaler (budesonide/albuterol) against another asthma inhaler in adults whose asthma is not well controlled on their current medications. It aims to see if the new inhaler can reduce serious asthma attacks and improve symptoms.
Hear when a new Asthma Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.